News - Avandia

Filter

Current filters:

Avandia

Popular Filters

Majority vote from FDA advisory panel to ease restrictions on GSK's Avandia

07-06-2013

A joint advisory committee to the US Food and Drug Administration (FDA) voted to continue to make UK…

AvandiaDiabetesGlaxoSmithKlineNorth AmericaPharmaceuticalRegulation

Research shows diabetes drug rosiglitazone improves memory

21-11-2012

Rosiglitazone, the active ingredient of GlaxoSmithKline's diabetes drug Avandia, has shown promise as…

AvandiaDiabetesGlaxoSmithKlineNeurologicalPharmaceuticalResearchrosiglitazone

Two drugs better than one to treat youth with type 2 diabetes

30-04-2012

A combination of two diabetes drugs, metformin and rosiglitazone (the active ingredient of GlaxoSmithKline's…

AvandiaDiabetesmetforminPharmaceuticalResearchrosiglitazone

GlaxoSmithKline finalizes $3 billion deal with US government over marketing practices

04-11-2011

UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday that it has reached an agreement in principle…

AvandiaFinancialGlaxoSmithKlineLegalNorth AmericaPharmaceutical

New twist in diabetes drugs could reduce life-threatening side effects

12-09-2011

Researchers from Dana-Farber Cancer Institute in Boston and the Scripps Research Institute in Jupiter,…

ActosAvandiaDiabetesGlaxoSmithKlinePharmaceuticalResearchTakeda Pharmaceuticals

GlaxoSmithKline’s diabetes drug Avandia to be restricted on US market

20-05-2011

As part of a US Food and Drug Administration re-assessment of UK drug giant GlaxoSmithKline’s troubled…

AvandiaDiabetesGlaxoSmithKlineNorth AmericaPharmaceuticalRegulation

Back to top